Tracking the future: Long-Term study monitors advanced cancer patients after CAR t therapy
NCT ID NCT06508775
Summary
This study aims to monitor the long-term safety and effectiveness of Miltenyi's CAR T cell therapies in patients who were treated at least a year ago. It will follow 40 patients with various cancers, including lymphoma, leukemia, and melanoma, to check for any late side effects and see if the cancer returns. The main goal is to understand the lasting impact of these advanced treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PEDIATRIC ALL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Charité Universitätsmedizin Berlin
RECRUITINGBerlin, 13353, Germany
-
Uniklinikum Erlangen
ACTIVE_NOT_RECRUITINGErlangen, 91054, Germany
-
Universitäts-Kinderklinik Würzburg
ACTIVE_NOT_RECRUITINGWürzburg, 97080, Germany
-
Universitätsklinikum Köln
ACTIVE_NOT_RECRUITINGCologne, 50937, Germany
-
Universitätsklinikum Münster
RECRUITINGMünster, 48149, Germany
-
Universitätsklinikum Tübingen
ACTIVE_NOT_RECRUITINGTübingen, 72076, Germany
-
Universitätsmedizin Göttingen
ACTIVE_NOT_RECRUITINGGöttingen, 37075, Germany
Conditions
Explore the condition pages connected to this study.